期刊文献+

针灸辅助肝动脉化疗栓塞术对原发性肝癌中医证候、生活质量和细胞免疫的影响 被引量:10

Influence of acupuncture and moxibustion assisted transcatheter arterial chemoembolization for TCM syndrome,quality of life and cellular immunity of primary liver cancer
下载PDF
导出
摘要 目的:探讨针灸辅助肝动脉化疗栓塞术(TACE)对原发性肝癌中医证候、生活质量和细胞免疫的影响。方法:收治原发性肝癌患者76例,随机分为观察组和对照组。对照组采用TACE及术后常规西药对症治疗,观察组在对照组的基础上加用针灸辅助治疗,比较两组治疗效果。结果:观察组术后第1天T淋巴细胞亚群、NK细胞及术后第5天NK细胞与对照组比较,差异有统计学意义(P<0.05)。治疗后,观察组KPS评分改善情况和中医临床症候总有效率明显优于对照组(P<0.05)。结论:针灸辅助TACE能有效提高原发性肝癌患者的细胞免疫功能及临床疗效,改善患者的生活质量。 Objective:To explore the influence of acupuncture and moxibustion assisted transcatheter arterial chemoembolization(TACE)for TCM syndrome,quality of life and cellular immunity of primary liver cancer.Methods:76patients with primary liver cancer were selected.They were randomly divided into the observation group and the control group.The control group was treated with TACE and conventional western,and the observation group added acupuncture and moxibustion on the basis of the control group.We compared the therapeutic effect of two groups.Results:The differences of lymphocyte subsets and NK cells at the first day after surgery and NK cells at the fifth days after surgery between the observation group and the control group were statistically significant(P<0.05).After treatment,the improvement of KPS score and the total effective rate of TCM syndrome in the observation group were significantly better than those in the control group(P<0.05).Conclusion:Acupuncture and moxibustion assisted transcatheter arterial chemoembolization can effectively improve the cellular immune function and clinical efficacy of patients with primary liver cancer,and improve the quality of life of patients.
作者 熊慧生 李倩 Xiong Huisheng;Li Qian(Institute of Tumor of Chongqing City 404100)
出处 《中国社区医师》 2017年第30期108-109,111,共3页 Chinese Community Doctors
关键词 原发性肝癌 针灸疗法 肝动脉栓塞 生活质量 细胞免疫 Primary liver cancer Acupuncture and moxibustion Hepatic artery embolization Quality of life cellular immunity
  • 相关文献

参考文献6

二级参考文献30

  • 1Zheng-GangRen Zhi-YingLin Jing-LinXia Sheng-LongYe Zeng-ChenMa Qing-HaiYe Lun-XiuQin Zhi-QuanWu JiaFan Zhao-YouTang.Postoperative adjuvant arterial chemoembolization improves survival of hepatocellular carcinoma patients with risk factors for residual tumor:A retrospective control study[J].World Journal of Gastroenterology,2004,10(19):2791-2794. 被引量:83
  • 2陈德成 等.中国针灸独穴疗法[M].长春:吉林科学技术出版社,1992.77.
  • 3Mizukoshi E, Nakamoto Y, Arai K, et al. Comparative analysis of various tumor associated antigen specific t cell responses in patients with hepatocellular carcinoma[J]. Hepatology, 2011, 53: 1206 1216.
  • 4Fu JL, Xu DP, Liu ZW, et al. Increased regulatory T cells correlate with CD8 T cell impairment and poor survival in hepatocellular carcinoma patients[J]. Gastroenterology, 2007, 132: 2328 2339.
  • 5O’Beirne JP, Harrison PM. The role of the immune system in the control of hepatocellular carcinoma[J]. Eur J Gastroenterol Hepatol. 2004, 16: 1257 1260.
  • 6Cho Y, Miyamoto M, Kato K, et al. CD4+ and CD8+ T cells cooperate to improve prognosis of patients with esophageal squamous cell carcinoma[J]. Cancer Res, 2003, 63: 1555 1559.
  • 7Chen X, Du Y, Huang ZM. CD4+ CD25+ Treg derived from hepatocellular carcinoma mice inhibits tumor immunity[J]. Immunol Lett, 2012, 148: 83 89.
  • 8Almeida AR, Ciernik IF, Sallusto F, et al. CD4+ CD25+ Treg regulate the contribution of CD8+ T cell subsets in repopulation of the lymphopenic environment[J]. Eur J Immunol, 2010, 40: 3478 3488.
  • 9Mcnally A, Hill GR, Sparwasser T, et al. CD4+ CD25+ regulatory T cells control CD8+ T cell effector differentiation by modulating IL 2 homeostasis[J]. Proc Natl Acad Sci USA, 2011, 108: 7529 7534.
  • 10Zhao F, Korangy F, Greten TF. Cellular immune suppressor mechanisms in patients with hepatocellular carcinoma[J]. Dig Dis, 2012, 30: 477 482.

共引文献84

同被引文献202

引证文献10

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部